Protagonist Therapeutics (PTGX) Ownership

PTGX$130.95-3.43 -2.55%
BiotechnologyGrowth StockHigh Quality
Compare
Market cap$8.55BEnterprise value$8.28BRevenue (TTM)$551.69MMarket position—

Score

68
Bullish
Value
34
Quality
77
Growth
93

Ownership data loads after the page opens.

Protagonist Therapeutics (PTGX) Ownership

PTGX price $130.95 -3.43 -2.55%

Ticker
PTGX
Price
$130.95
Change
-3.43 -2.55%
Market cap
$8.55B
P/E
24.97
Forward P/E
144.00
Dividend yield
0.00%
Beta
1.79
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
34
Quality
77
Growth
93

Stocklytics score rationale: value 34, quality 77, growth 93.

AI Score 65. Protagonist Therapeutics, Inc. has a market cap of $9.28 billion and is engaged in promising Phase II clinical trials for its therapies, indicating potential growth

Insights · Forecast · Financials · Learn

Stocklytics home · Screener